Management of type 2 diabetes mellitus in older adults: eight case studies with focus SGLT-2 inhibitors and metformin

References

• Satman I, Yilmaz T, Sengül A, et al. Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish diabetes epidemiology study (TURDEP). Diabetes Care. 2002;25(9):1551–1556. (In eng).
   Google Scholar
• Satman I, Omer B, Tutuncu Y, et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol. 2013;28(2):169–180. (In eng).
   Google Scholar
• Bahat G, Tufan F, Bahat Z, et al. Comorbidities, polypharmacy, functionality and nutritional status in Turkish community-dwelling female elderly. Aging Clin Exp Res. 2014;26(3):255–259. (In eng).
   Google Scholar
• Bahat G, Tufan F, Bahat Z, et al. Assessments of functional status, comorbidities, polypharmacy, nutritional status and sarcopenia in Turkish community-dwelling male elderly. Aging Male. 2013;16(2):67–72. (In eng).
   Google Scholar
• Volkert D, Beck AM, Cederholm T, et al. ESPEN guideline on clinical nutrition and hydration in geriatrics. Clin Nutr. 2019;38(1):10–47. (In eng).
   Google Scholar
• Davies MJDAD, Fradkin J, Kernan WN, et al. Management of hyperglycemia in Type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018;41(12). DOI:https://doi.org/10.2337/dci18-0033
   Google Scholar
• Strandberg TE, Petrovic M, Benetos A. SGLT-2 inhibitors for people with type 2 diabetes. Lancet. 2019;394(10198):560. (In eng).
   Google Scholar
• Türkiye Endokrin ve Metabolizma Derneği (TEMD). Diabetes Mellitus ve Komplikasyonlarinin Tanı, Tedavi ve İzlem Kılavuzu. Bayt Bilimsel Araştırmalar. Basın Publisher; Ankara. 2020. (ISBN: 978-605-4011-40-7).
   Google Scholar
• Wexler DJND, Mulder JE Metformin in the treatment of adults with type 2 diabetes mellitus UpToDate 2021(access date: Mar 2021).
   Google Scholar
• Samaras KMS, Crawford JD, Kochan NA, et al. Metformin use is associated with slowed cognitive decline and reduced incident dementia in older adults with type 2 diabetes: the Sydney memory and ageing study. Diabetes Care. 2020;43(11):2691–2701.
   Google Scholar
• Romdhoniyyah DFHS, Cheyne CP, Beare NAV. Metformin, a potential role in age-related macular degeneration: a systematic review and meta-analysis. Ophthalmol Ther. 2021;10(2):245–260.
   Google Scholar
• Metformin. Drug information. UpToDate Lexicomp, Inc 2021. [cited Mar 2021].
   Google Scholar
• Richy FF, Sabidó-Espin M, Guedes S, et al. Incidence of lactic acidosis in patients with type 2 diabetes with and without renal impairment treated with metformin: a retrospective cohort study. Diabetes Care. 2014;37(8):2291–2295. (In eng).
   Google Scholar
• Bahat G, Ilhan B, Erdogan T, et al. Turkish inappropriate medication use in the elderly (TIME) criteria to improve prescribing in older adults: TIME-to-STOP/TIME-to-START. Eur Geriatric Med. 2020;11(3):491–498. (In eng).
   Google Scholar
• Bahat GİB, Erdogan T, Oren MM, et al. International validation of the Turkish inappropriate medication use in the elderly. Drugs&Aging. 2021. DOI:https://doi.org/10.1007/s40266-021-00855-5.
   Google Scholar
• Bahat G, Erdogan T, Karan MA. Need for increased awareness for avoiding metformin treatment in malnourished older adults with diabetes mellitus. Clin Nutr. 2020;39(1):322. (In eng).
   Google Scholar
• Empagliflozin. Drug information Lexicomp, UpToDate 2021:[cited Mar 2021].
   Google Scholar
• Dapagliflozin. Drug information. Lexicomp, UpToDate 2021:[cited Mar 2021].
   Google Scholar
• https://www.ema.europa.eu/en/documents/product-information/forxiga-epar-product-information_en.pdf.AccessdateJune 01, 2021
   Google Scholar
• Standards of Medical Carefailure. Diabetes Care. 2020;22(2):196–213. (In eng).
   Google Scholar
• Seferović PM, Coats AJS, Ponikowski P, et al. European society of cardiology/heart failure association position paper on the role and safety of new glucose-lowering drugs in patients with heart failure. Eur J Heart Fail. 2020;22(2):196–213. (In eng).
   Google Scholar
• Ni L, Yuan C, Chen G, et al. SGLT2i: beyond the glucose-lowering effect. Cardiovasc Diabetol. 2020;19(1):98. (In eng).
   Google Scholar
• Han SJHK, Lee N, Kim DJ. Effectiveness and safety of sodium-glucose co-transporter-2 inhibitors compared with dipeptidyl peptidase-4 inhibitors in older adults with type 2 diabetes: a nationwide population-based study. Diabetes Obes Metab. 2021;23(3):682–691.
   Google Scholar
• Kim J, Ahn CW, Fang S, et al. Association between metformin dose and vitamin B12 deficiency in patients with type 2 diabetes. Medicine (Baltimore). 2019;98(46):e17918. (In eng).
   Google Scholar
• Lachner C, Steinle NI, Regenold WT. The neuropsychiatry of vitamin B12 deficiency in elderly patients. J Neuropsychiatry Clin Neurosci. 2012;24(1):5–15. (In eng).
   Google Scholar
• Ocampo Chaparro JM. Vitamin B12 deficit and development of geriatric syndromes. Colomb Med (Cali). 2013;44(1):42–45. (In eng). .
   Google Scholar
• Aroda VR, Edelstein SL, Goldberg RB, et al. Long-term metformin use and vitamin B12 deficiency in the diabetes prevention program outcomes study. J Clin Endocrinol Metab. 2016;101(4):1754–1761. (In eng).
   Google Scholar
• Sun W, Li G, Lai Z, et al. Subacute combined degeneration of the spinal cord and hydrocephalus associated with vitamin B12 deficiency. World Neurosurg. 2019;128:277–283. (In eng).
   Google Scholar
• Wang Y, Mao Q, Zhang C, et al. [A case of severe orthostatic hypotension induced by vitamin B12 deficiency]. Zhonghua Xin Xue Guan Bing Za Zhi. 2021;49(1):76–78. (In chi).
   Google Scholar
• https://www.ema.europa.eu/en/documents/referral/jardiance-article-20-procedure-annex-i-iii_en.pdf.
   Google Scholar
• LeRoith D, Biessels GJ, Braithwaite SS, et al. Treatment of diabetes in older adults: an endocrine society* clinical practice guideline. J Clin Endocrinol Metab. 2019;104(5):1520–1574. (In eng).
   Google Scholar
• Perkovic VBS, Bakris GL Treatment of diabetic kidney disease UpToDate 2021:[cited Mar 2021].
   Google Scholar
• Lipska KJ, Bailey CJ, Inzucchi SE. Use of metformin in the setting of mild-to-moderate renal insufficiency. Diabetes Care. 2011;34(6):1431–1437. (In eng).
   Google Scholar
• KDIGO. 2020 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 2020;98(4s):S1–s115. (In eng).
   Google Scholar
• Lalau JD, Kajbaf F, Bennis Y, et al. Metformin treatment in patients with type 2 diabetes and chronic kidney disease stages 3A, 3B, or 4. Diabetes Care. 2018;41(3):547–553. (In eng).
   Google Scholar
• Garber AJ, Handelsman Y, Grunberger G, et al. Consensus statement by the American association of clinical endocrinologists and American college of endocrinology on the comprehensive type 2 diabetes management algorithm - 2020 executive summary. Endocr Pract. 2020;26(1):107–139. (In eng).
   Google Scholar
• Wexler DJMetformin in the treatment of adults with type 2 diabetes mellitus. UpToDate 2021:[cited Mar 2021].http://www.uptodate.com
   Google Scholar
• https://www.ema.europa.eu/en/documents/product-information/jardiance-epar-product-information_en.pdf.AccessdateJune 01, 2021
   Google Scholar